Surgeryl.l and irradiation"' have been the primary treatments for patients with invasive thymoma. The role of chemotherapy in treating patients with thymoma is not well defined; however, recent reports of complete responses to cisplatin alone"-" and to regimens of combined chemotherapy1.' " suggest that this tumor might be relatively sensitive to cytotoxic drugs.
We have observed two complete remissions which resulted from treatment with relatively low dosages of cyclophosphamide, doxorubicin, and vincristine. One patient had intrathoracic recurrence only, and the other had disseminated disease involving the liver and lungs. The potential role of chemotherapy and its relationship to radiation therapy are discussed.
In September 1978, a 52-year-old white woman presented with menorrhagia of six months' duration. She had no other complaints, and the findings from physical examination were unremarkable. Uterine dilatation and curettage revealed well-differentiated adenocarcinoma of the endometrium. A chest roentgenogram at that time disclosed an anterior mediastinal mass. Prior to definitive therapy for the uterine tumor, left thoracotomy was performed, and biopsy of the mediastinal mass revealed malignant lymphoepithelial thymoma. The mediastinal tumor was intimately related to residual thymic tissue. Histologically, no resemblance to the endometrial tumor could be found, with the mediastinal tumor revealing fine fibrovascular septae which separated the cells into cords and bundles on histologic examination. The cells of the tumor were large, and their morphologic form varied from round to spindle.
Nuclide scans of liver, brain, and hone were unremarkable. The patient received 3, 200 Following completion of the pelvic irradiation, a sternotomy with partial resection of the mediastinal tumor was performed in November 1978. The tumor had invaded the sl~rrounding tisst~es, with involvement of the left phrenic nerve, pl~lmonary artery, pleura, and pericardium. Because the thymic tumor was incompletely resected, mediastinal irradiation was given after surgery This treatment consisted of 3,000 rads in 15 fractions given through an anterior-posterior portal, followed by 3,000 rads in 15 fractions given by an oblique beam. In December 1978, treatment of the endometrial cancer was completed by performing a hysterectomy. only residual superficial endometrial carcinoma was found. In April 1979, an asymptomatic 8 X 11-cm plellral-hased mass was noted in the left thorax on the chest x-ray film ( Fig 1A) and computerized tomographic scan (Fig 1C) . A gallillm scan demonstrated increased activity in the same region (Fig 1B) . Perc~~taneous needle biopsy of this mass demonstrated lymphoepithelial thymoma. Additional radiation therapy was not feasihle at this time because the field of treatment would have overlapped previollsly irradiated areas. Therefore, starting on May 4, 1979, doxorr~hicin (30 mejsq m), cyclophosophamide (500 mglsq m), and vincristine (1 mgisq m) were administered intraveno~~sly every 21 days. Three months later, both the chest x-ray film (Fig 2A) and gallium scan ( Fig  2B) were improved. The compllterized tomographic scan revealed resolution of the mass, with only minimal plellral irregularity ( Fig  2C) . Chemotherapy was discontinued after six courses, two cycles after complete remission had been achieved.
Five months after observing complete regression of the tumor (eight months after initiation ofchemotherapy). a 6 x 4-cm lesion was observed on the chest x-ray film, which was confirmed on gallium scan. Prednisone (200 mg daily for five consecutive clays) and hleomycin (15 mg intravenously) were added to the previo~ls regimen. The mass decreased to 2 x 2-cm after two cycles. Doxor~~hicin was discontinued in July 1980 at a cumulative dosage of425 mejsq m. A month later, the patient presented with congestive heart fail~~re. pres~~mably secondary to doxoruhicin-induce cardiomyopathy, and all chemotherapy was stopped. Within two months, progression of the tumor was again noted, and a single course of cisplatin (50 mejsq m), cyclophosphamide (700 mdsq m), and vincristine (1 mglsq m) was administered without response. In Novemher 1980. a total of 3,000 rads was administered to the left pleural mass. No tumor was detectable on the chest x-ray film one month after completion of irradiation. The patient remains asymptomatic and without evidence of disease as dncumented by chest x-ray film$ and gallium scan 37 months after receiving radiation therapy and Fj3 FICUHE 1. A (top). Roentgenogram depicts left pleural-based mass which was present immediately prior to starting chemotherapy in case 1. This mass was cnnfirmed on gallium scan (B. middle) and thoracic romputerized tomogram (C. bottom). by dense stroma. The cells were pleomorphic, varying in shape from round to sdndle. The tumor was associated with an area of mature lymphocytes, thymic epithelial cells, and Hassall's corpuscles. The patient's postoperative course was complicated by mediastinitis requiring surgical drainage, antibiotics, and wound irrigations, with complete resolution of infection; however, three months after surgery, she was hospitalized because of increasing dyspnea. Oral temperature was 3g°C, and respirations were 36lmin. The wound had healed completely and was free of inflammation. Rales were detected in both pulmonary bases. Hepatomegaly was noted, with the edge of the liver palpable 7 cm below the right costal margin, 4 cm below the xiphoid process.
A chest x-ray film showed mediastinal widening and bilateral pulmonary nodules (Fig 3A) . A liver scan with nuclides demonstrated multiple filling defects. Following resolution ofthe fever with administration of broad-spectrum antibiotics, the patient received intravenous doxorubicin (40 mg/sq m), cyclophosphamide (400 mgl sq m), and vincristine (1 mgtsq m), with courses repeated every three weeks for a total of ten courses. Within three months of initiation of chemotherapy, the chest roentgenogram (Fig 3B) demonstrated complete resolution of the mediastinal enlargement and pulmonary nodules, and the patient's liver was palpable at the right costal margin. A liver scan on Nov 11, 1981 showed resolution of the previously noted filling defects.
The patient remained asymptomatic until four months later (seven months after initiation of chemotherapy), when she complained of cough. No clinical evidence of hepatomegaly was noted at this time, but her chest x-ray film demonstrated mediastinal widening. Chemotherapy was discontinued, and mediastinal radiation was given (3,000 rads in ten fractions). Two months later, progressive disease was noted in the left axilla. The patient received two courses of cisplatin (50 mg/sq m) at three-week intervals without response, and new progressive pulmonary and hepatic metastases developed. She eventually died from respiratory insufficiency secondary to progressive thoracic tumor eight months after recurrence. Permission for autopsy was not obtained. histologically as lymphocytic, lymphoepithelial, epithelial, or spindle cell type.1.2~1"18 Prognosis is related to the presence or absence of invasion of the surrounding tissues, rather than to the histologic appearance. 1.2.17.1f1 In a series of 138 patients, excision produced a five-year survival rate of 80 percent in patients with noninvasive thymoma, in contrast to a five-year survival rate of 23 percent in patients with invasive thymoma.' Following radiation therapy alone, longterm survival has been ~e p o r t e d .~" Postoperative adjuvant radiation therapy may result in longer survival than surgery a l~n e , " -~~'~ but these analyses need cautious interpretation, as controlled trials have not been available in this uncommon tumor.
Invasive thymomas recur most commonly within the thorax, with a predilection for pleural involvement.'." Distant metastases are r a~e . ' .~.~ Frequently, the treatment of intrathoracic recurrence is difficult, not only because reexcision may not be possible due to the location or to the extent of the tumor, but also because previous radiation therapy may preclude retreatment in the same treatment port. In these situations where local control is inadequate, as well as in the rare cases presenting with distant disease, chemotherapy might prove beneficial.
Little is known about the chemosensitivity of thymomas. Many investigators have included glucocorticoids alone or in combination with other agents for the treatment of thymoma. represent antineoplastic effect in patients with a lymphocytic component.
In t h e few n~~m b e r s ofcases successfully treated with nonsteroid-containing chemotherapy, cisplatin has demonstrated activity. Indeed, d~~r i n g a phase-1 trial of cisplatin, the only partial remission noted was in a patient with a thymoma which lasted 13 month^.^' Subsequent reports of responses to cisplatin alone'2.'1.2" or as part of a combined regimen',' have been recently detailed I,y several al~thors. In three of these cases, complete remissions were demonstrated, lasting from 10 to 24 months.
C h e m o t h e r a p e u t i c regimens not containing cisplatin have been utilized in only a small number of patient^.""'^' With t h e exception of a complete remission achieved w i t h d o x o r r~b i c i n a n d cyclophosphamide, t h e majority of these responses have been incomplete and of brief duration. Although this report c o n f i r m s t h e a c t i v i t y of d o x o r u b i c i n a n d cyclophosphamide (cornhined chemotherapy) for metastatic thymoma, t h e d~~r a t i o n of remissions were relatively brief in these cases, compared to those reported with isp plat in.'^'"^" In both cases presented in this report, t~~r n o r recr~rred at the site of bulky disease. As irradiation has heen reported to prodr~ce prolonged remissions in invasive thymoma,".'" its role in management of this disc.ase should not h e overlooked. In case 1, radiation therapy for intrathoracic recurrence was initially not feasible h e c a~~s e of an increased risk of complications from overlapping fields of treatment. S u l~s e c~r~c~~t to a response to chemotherapy, aclditional radiation therapy could b e administered safely to the site of rc.cr~rrc.nt tr~mor. Thc. sustained completta rernission in this case suggests that consolidation with ratliation therapv may b e beneficial in selected patients following maximal response to c h e m o t h e r~p y .
In summary, this report provides further evidence that invasive thymoma is a chemosensitive tumor. A prolongecl second remission with the addition of further radiation therapy (case l) was also noted. Additional data regarding sensitivity of thymomas to chemotherapy are needed and should become available from at least two ongoing cooperative group trials evaluating cisplatin alone (Eastern Cooperative Oncology Croup) and t h e combined regimen of cisplatin plus doxorubicin pl11s cyclophosphamide alone (extensive disease) or with radiation therapy (limited disease) by the Thymoma Intergroup Stl~dy.
